Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hemolytic anemia in which the erythrocytes are abnormally sensitive to lysis by complement. A functional deficiency of membrane-associated complement regulators has been demonstrated on PNH erythrocytes. The two factor H-like proteins, the C3b receptor (CR1) and the decay-accelerating factor (DAF), were isolated from normal human erythrocytes, and specific antisera were prepared. Selective inhibition of the two proteins on normal erythrocytes by the antisera demonstrated (i) that the factor responsible for accelerated decay of erythrocyte-bound C3 convertase is DAF and (ii) that the cofactor required for inactivation of erythrocyte-bound C3b by factor I is CR1. PNH erythrocytes were deficient in both of these activities. Erythrocytes deficient in CR1, which were obtained from an apparently healthy individual, exhibited normal DAF activity but no factor I cofactor activity. These cells were not susceptible to complement-mediated lysis in acidified human serum, whereas PNH erythrocytes and Pronase-treated human erythrocytes (which lack DAF and CR1 activities) were lysed by this treatment. It is suggested that the protein primarily responsible for preventing complement activation on normal human erythrocytes is DAF. AMr 73,000 protein isolated from the normal erythrocyte membranes of one PNH patient by using anti-DAF IgG was largely absent from the abnormal erythrocytes of this individual, suggesting that PNH cells lack the DAF protein. CR1 antigen, however, was present on the abnormal PNH erythrocytes. The results suggest that the primary molecular defect underlying the clinical manifestations of PNH may be the lack of the membrane-associated DAF protein and that the abnormal cells may also exhibit impaired CR1 function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
THE ORGANIZATION OF PROTEINS IN THE HUMAN RED BLOOD CELL MEMBRANE
Steck, T. L. (1974) · The Journal of Cell Biology · doi:10.1083/jcb.62.1.1 · Cited by 1,552
Pangburn, M. K., Schreiber, R. D., & Müller-Eberhard, H. J. (1977) · The Journal of experimental medicine · doi:10.1084/jem.146.1.257 · Cited by 684
Self-citationFearon, D. (1980) · The Journal of Experimental Medicine · doi:10.1084/jem.152.1.20 · Cited by 644
Modulation of the alternative complement pathways by beta 1 H globulin.
Whaley, K., & Ruddy, S. (1976) · The Journal of experimental medicine · doi:10.1084/jem.144.5.1147 · Cited by 583
Control of the amplification convertase of complement by the plasma protein beta1H.
Weiler, J. M., Daha, M. R., Austen, K. F., & Fearon, D. T. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.9.3268 · Cited by 570
Pangburn, M. K., Schreiber, R. D., & Müller-Eberhard, H. J. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.3.856 · Cited by 446
Self-citationFearon, D. T. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.11.5867 · Cited by 440
Large scale isolation of functionally active components of the human complement system.
Hammer, C. H., Wirtz, G. H., Renfer, L., Gresham, H. D., & Tack, B. F. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69557-8 · Cited by 437
Pangburn, M. K., & Müller-Eberhard, H. J. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.5.2416 · Cited by 346
Self-citation
Cited by
Infectious diseases associated with complement deficiencies
Figueroa, J. E., & Densen, P. (1991) · Clinical Microbiology Reviews · doi:10.1128/cmr.4.3.359 · Cited by 729
Medof, M. E., Kinoshita, T., & Nussenzweig, V (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.5.1558 · Cited by 561
Control of the Complement System
Uszewski, M. K., Farries, T. C., Lublin, D. M., Rooney, I. A., & Atkinson, J. P. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60868-8 · Cited by 500
Decay-Accelerating Factor: Biochemistry, Molecular Biology, And Function
Lublin, D. (1989) · Annual Review of Immunology · doi:10.1146/annurev.immunol.7.1.35 · Cited by 496
Holguin, M. H., Fredrick, L. R., Bernshaw, N. J., Wilcox, L. A., & Parker, C. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114172 · Cited by 403
Kinoshita, T., Medof, M. E., Silber, R., & Nussenzweig, V (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.1.75 · Cited by 400
Seya, T., Turner, J. R., & Atkinson, J. P. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.4.837 · Cited by 398
Rapid induction of the expression of proto-oncogene fos during human monocytic differentiation
Mitchell, R. L., Zokas, L., Schreiber, R. D., & Verma, I. M. (1985) · Cell · doi:10.1016/0092-8674(85)90324-1 · Cited by 395
Self-citationParoxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene.
Bessler, M., Mason, P. J., Hillmen, P., Miyata, T., Yamada, N., Takeda, J., Luzzatto, L., & Kinoshita, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06240.x · Cited by 389
Davitz, M. A., Low, M. G., & Nussenzweig, V (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.5.1150 · Cited by 353
Membrane complement regulatory proteins
Kim, D. D., & Song, W.-C. (2006) · Clinical Immunology · doi:10.1016/j.clim.2005.10.014 · Cited by 353
Yamashina, M., Ueda, E., Kinoshita, T., Takami, T., Ojima, A., Ono, H., Tanaka, H., Kondo, N., Orii, T., Okada, N., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010253231707 · Cited by 351
Membrane Complement Receptors Specific for Bound Fragments of C3
Ross, G. D., & Medof, M. E. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60341-7 · Cited by 308
The alternative pathway of complement
Pangburn, M. K., & Müller-Eberhard, H. J. (1984) · Springer Seminars in Immunopathology · doi:10.1007/bf01893019 · Cited by 291
Self-citationDecay accelerating factor of complement is anchored to cells by a C-terminal glycolipid
Medof, M. E., Walter, E. I., Roberts, W. L., Haas, R., & Rosenberry, T. L. (1986) · Biochemistry · doi:10.1021/bi00370a003 · Cited by 286
Membrane proteins that protect against complement lysis
Morgan, B. P., & Meri, S. (1994) · Springer Seminars in Immunopathology · doi:10.1007/bf01837366 · Cited by 263
Damage to mammalian cells by proteins that form transmembrane pores
Bhakdi, S., & Tranum-Jensen, J. (2005) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/bfb0027646 · Cited by 260
Harjunpää, Junnikkala, & Meri (2000) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2000.00745.x · Cited by 256
Medof, M. E., Lublin, D. M., Holers, V. M., Ayers, D. J., Getty, R. R., Leykam, J. F., Atkinson, J. P., & Tykocinski, M. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.2007 · Cited by 254
The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo
Liu, J., Miwa, T., Hilliard, B., Chen, Y., Lambris, J. D., Wells, A. D., & Song, W.-C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040863 · Cited by 252
Ram, S., Shaughnessy, J., DeOliveira, R. B., Lewis, L. A., Gulati, S., & Rice, P. A. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.05.016 · Cited by 35
Metadata
- Authors
- Pangburn, M. K., Schreiber, R. D., & Müller-Eberhard, H. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1983-09
- Volume
- 80
- Issue
- 17
- Pages
- 5430-5434
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2072926018
- Cited by
- 317
- References
- 20
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.